Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AMBS > SEC Filings for AMBS > Form 8-K on 9-Jan-2013All Recent SEC Filings

Show all filings for AMARANTUS BIOSCIENCES, INC.



Other Events, Financial Statements and Exhibits

Item 8.01 Other Events

On 8 January 2013, Amarantus Bioscience, Inc. released the data developed from its research grant from the Michael J. Fox Foundation. The data was presented by the Company's Chief Science Officer, Dr. John W. Commissiong, at the OneMed 2013 Forum.

There are currently more than 6 million Parkinson's disease patients worldwide, and that number is expected to double by 2032. Amarantus' lead drug candidate, MANF (Mesencephalic Astrocyte-Derived Neurothrophic Factor) is an anti-apoptratic therapeutic protein, which the research data demonstrates, provides promising Parkinson's disease treatment.

Parkinson's Disease is believed to be caused by a decrease in dopamine in the substantia nigra area of the brain. Independent studies, which were partially funded by a research grant from the Michael J. Fox Foundation for Parkinson's disease, demonstrate MANF increases the density of DA (dopaminergic neurons) terminals and the concentration of dopamine in the striatum whereas GDNF (Glial Cell-Line Derived Neurotrophic Factor), another drug candidate for the treatment of Parkinson's disease, does not. Other independent studies conducted under the grant at the UCLA Medical School demonstrate that MANF significantly reduces behavioral deficits associated with Parkinson's disease whereas GDNF does not.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

Exhibit No.

99.1 Presentation material presented at the OneMed 2013 on the effect of MANF in the treatment of Parkinson's disease.

99.2 Press release: Amarantus BioScience Announces Positive Efficacy Data for MANF in a Nigral Delivery Neurorestoration Animal Model of Parkinson's Disease

  Add AMBS to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AMBS - All Recent SEC Filings
Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.